D-0248-2018 Class III Terminated
FDA drug recall D-0248-2018 was initiated by Ascent Pharmaceuticals, Inc. on Jan 22, 2018 and is designated Class III. Reason for recall: Labeling; Label Error Not Elsewhere Classified; label missing controlled substance CII symbol The recall status is terminated (terminated Apr 23, 2018). Affected quantity: 45,875 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 7, 2018
- Initiation Date
- Jan 22, 2018
- Termination Date
- Apr 23, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 45,875 bottles
Product description
Oxycodone Hydrochloride Tablets, USP 15 mg, 100 count bottles, Rx only, Manufactured for Camber Pharmaceuticals, Inc., Piscataway, NJ, Manufactured by: Ascent Pharmaceuticals, Inc., Central Islip, NY --- NDC 31722-917-01
Reason for recall
Labeling; Label Error Not Elsewhere Classified; label missing controlled substance CII symbol
Distribution pattern
Nationwide
Code information
Lot Numbers: 17080591 and 17080619, exp 07/19; 17110907 and 17110908, exp 10/19; and 17120986, exp 11/19
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0248-2018
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026